Massachusetts, which adopted the nation’s first pulmonary hypertension (PH) law in January, has named the first members of an expert…
Articles by Patrícia Silva, PhD
A simple test with cord blood could predict which babies are at risk of developing a severe lung disease called bronchopulmonary…
The European Medicines Agency (EMA) has completed its review of Uptravi (selexipag) and concluded that doctors may continue prescribing…
Due to regulatory delays, the U.S. launch of United Therapeutics‘s implanted pump system for the delivery of Remodulin…
Northwestern Medicine’s Pulmonary Vascular Disease Program has won accreditation as a Comprehensive Care Center by the …
England’s National Health Service (NHS) has added three treatments to the options it offers patients with rare diseases, one of which…
Apollo Therapeutics has approved £8.5 million ($10.6 million) to fund four projects, including a small and large molecule discovery…
The European Medicines Agency (EMA) is reviewing the safety of Uptravi (selexipag) after the deaths of five patients with pulmonary arterial…
Terrence Jenkins, second-year celebrity ambassador of the Pulmonary Hypertension Association (PHA), will appear in a print and digital public…
The Pulmonary Hypertension Association (PHA) will present two abstracts with data from the PHA registry, which collects information on…
Actelion, which manufactures treatments for conditions like pulmonary arterial hypertension (PAH), will be acquired by Johnson & Johnson…
Bayer and Merck recently presented positive results from five data sets that evaluated the clinical benefits of Adempas…